Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
Stanford University
Poseida Therapeutics, Inc.
Dana-Farber Cancer Institute
LTZ Therapeutics, Inc.
The First Affiliated Hospital with Nanjing Medical University
Chengdu Zenitar Biomedical Technology Co., Ltd
Eli Lilly and Company
Virginia Commonwealth University
Miltenyi Biomedicine GmbH
Masonic Cancer Center, University of Minnesota
Stichting Hemato-Oncologie voor Volwassenen Nederland
Verismo Therapeutics
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University Health Network, Toronto
The First Affiliated Hospital of Soochow University
Sun Yat-sen University
University of Arizona
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Chengdu Zenitar Biomedical Technology Co., Ltd
University of Nebraska
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Insel Gruppe AG, University Hospital Bern
Medical University of Vienna
Florida International University
Masonic Cancer Center, University of Minnesota
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
ImmunityBio, Inc.
The First Affiliated Hospital of Xiamen University
The First Affiliated Hospital of Xiamen University
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Nkarta, Inc.
Université de Sherbrooke
University Medical Center Groningen
Zhejiang Provincial People's Hospital
Australasian Leukaemia and Lymphoma Group
Juno Therapeutics, a Subsidiary of Celgene
University Medical Center Groningen
Sunnybrook Health Sciences Centre
Athenex, Inc.
Atara Biotherapeutics
Centre Hospitalier Universitaire, Amiens
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Rush University Medical Center
Stanford University